A multifunctional carbon quantum dot overcoming the BBB for modulating amyloid aggregation and scavenging reactive oxygen species

Abstract

The abnormal aggregation of β-amyloid (Aβ), the accumulation of reactive oxygen species (ROS), and the presence of the blood-brain barrier (BBB) cause the prevention and treatment of Alzheimer's disease (AD) extremely difficult. In this study, we report multifunctional carbon quantum dots (CQDs) with red emission (RCQDs) for targeting Aβ42, modulating Aβ42 aggregation, overcoming the BBB, and scavenging ROS. RCQDs demonstrate exceptional targeting affinity for Aβ42 species, and exhibit high inhibition and disaggregation efficiencies against Aβ42 aggregates. Moreover, RCQDs possess outstanding scavenging abilities against the ROS in cells, thus resulting in the mitigation of cellular oxidative damages. RCQDs also exhibited strong penetration through the BBB in both in vitro and in vivo models, highlighting their potential for brain-targeted treatment. Further investigations using primary microglial cells confirm the anti-neuroinflammation properties of RCQDs. This study unprecedently demonstrates the therapeutic potential of unmodified pure CQDs for overcoming the BBB, targeting Aβ42 species, modulating Aβ42 aggregation and scavenging ROS, offering a promising candidate for the treatment of AD.